Floatz logo

Procarbazine

Precancerous/Nonmalignant Condition

Indiana UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Precancerous/Nonmalignant Condition cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Institut Paoli-Calmettes
Phase 2BB
ZIDOVUDINE
University of Miami
Phase 4BB
Selenium
SWOG Cancer Research Network
Phase 3BB
ETOPOSIDE
City of Hope Medical Center
Phase 2BB
Dextromethorphan
NCIC Clinical Trials Group
Phase 3BB

View all 18 →

Same molecule, other indications

Procarbazine is also rated in:

central nervous system neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
lymphomaDormant
BB
Indicative ·
69 / 100
View asset →
Adult Giant Cell GlioblastomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →